• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problem No Apparent Adverse Event (3189)
Patient Problem Skin Burning Sensation (4540)
Event Date 02/09/2024
Event Type  malfunction  
Manufacturer Narrative
D4: udi- (b)(4).The technical services provided the information regarding the chemical structure of reagent solution.The remainder of the investigation remains in progress.A supplemental report will be provided after completion.H3 other text : device discarded; single-use device.
 
Event Description
The consumer reported accidental exposure to the binaxnow covid-19 antigen self-test reagent on (b)(6) 2024.Per the consumer, she has been exposed to the reagent solution through the cut on her hand.The consumer reported experiencing a burning sensation at first that went away after washing the cut on her hand with water.The consumer confirmed that they had no effects from the reagent.No additional information was provided.
 
Event Description
The consumer reported accidental exposure to the binaxnow covid-19 antigen self-test reagent on (b)(6)2024.Per the consumer, she has been exposed to the reagent solution through the cut on her hand.The consumer reported experiencing a burning sensation at first that went away after washing the cut on her hand with water.The consumer confirmed that they had no effects from the reagent.No additional information was provided.
 
Manufacturer Narrative
D4: udi-(b)(4) a product deficiency was not reported or found.Technical service provided the safety data sheet.The reported health status is anticipated in nature and severity for binaxnow covid-19 ag card risk documentation.A supplemental report will be provided if any additional is obtained.H3 other text : device discarded; single-use device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key18704293
MDR Text Key335412573
Report Number1221359-2024-00181
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 02/23/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Catalogue Number195-160
Device Lot Number228743A
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/09/2024
Initial Date FDA Received02/14/2024
Supplement Dates Manufacturer Received02/21/2024
Supplement Dates FDA Received02/23/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/01/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age50 YR
Patient SexFemale
Patient Weight50 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-